Addition of oncolytic virus is as effective as addition of cytoreductive nephrectomy to the first-line treatment of anti-PD-1/anti-CTLA-4 antibodies in the murine metastatic renal cell carcinoma model

J.S. Park; W.S. Ham; M.E. Lee; W.S. Jang; K. Oh; N. Lee

doi:10.1016/j.annonc.2022.07.061

YUHSpace

BROWSE

0 174

Cited 0 times in

Addition of oncolytic virus is as effective as addition of cytoreductive nephrectomy to the first-line treatment of anti-PD-1/anti-CTLA-4 antibodies in the murine metastatic renal cell carcinoma model

Authors: J.S. Park ; W.S. Ham ; M.E. Lee ; W.S. Jang ; K. Oh ; N. Lee

Citation: ANNALS OF ONCOLOGY, Vol.33(Suppl 7) : S557, 2022-09

Journal Title: ANNALS OF ONCOLOGY

ISSN: 0923-7534

Issue Date: 2022-09

Full Text: https://www.sciencedirect.com/science/article/pii/S0923753422019123

DOI: 10.1016/j.annonc.2022.07.061

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers

URI: https://ir.ymlib.yonsei.ac.kr/handle/22282913/194334

사서에게 알리기

Show full item record Find it @ YMLIB

License

YUHSpace: Addition of oncolytic virus is as effective as addition of cytoreductive nephrectomy to the first-line treatment of anti-PD-1/anti-CTLA-4 antibodies in the murine metastatic renal cell carcinoma model

YUHSpace

BROWSE

Browse

Links